Evogene Declares The Sale Of Lavie Bio's Activity To ICL Completed

ICL Group Ltd (NYSE:ICL) is among the 13 Best Magnesium Stocks to Invest in Now. Evogene Ltd. announced the successful sale of its ag-biologicals subsidiary, Lavie Bio Ltd., to ICL Group Ltd (NYSE:ICL). The acquisition, which was first revealed on April 21, 2025, comprises Lavie Bio’s patented Biology Driven Design technology platform, microbial bank, pipeline of advanced development programs, and current commercial products, as well as the transfer of core individuals to ICL Group Ltd (NYSE:ICL). Evogene also sold off its MicroBoost AI for AG platform, a computational tool that speeds up the creation of microbial products in agriculture. Lavie Bio’s current commercial agreements and partnerships are unaffected by the transaction and continue to provide benefits to its shareholders.

CEO Ofer Haviv underlined the action as a strategic turning point that would multiply the company’s global reach and promote the growth of sustainable agriculture. Dr. Elinor Erez, VP R&D at ICL Group Ltd (NYSE:ICL), noted that bringing together Lavie Bio with ICL Group Ltd (NYSE:ICL)’s R&D, sales network, and agronomy teams boosts ICL Group Ltd (NYSE:ICL)’s innovation pipeline, cementing the company’s position in the global ag-biologicals market and promoting sustainable solutions at scale. It is one of the Best Magnesium Stocks.

While we acknowledge the potential of ICL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.